Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-09-26 Sale | 2025-09-30 4:41 pm | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 16,000 | $44.75 | $716,000 | 24,928 (Direct) | View |
| 2024-10-17 Sale | 2024-10-18 6:25 pm | Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director | 21,788 | $17.03 | $370,962 | 205,321 (Direct) | View |
| 2024-03-20 Sale | 2024-03-22 4:31 pm | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 60,000 | $44.14 | $2,648,150 | 18,536 (Direct) | View |
| 2024-03-07 Sale | 2024-03-11 12:54 pm | Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director | 12,195 | $50.88 | $620,443 | 14,860 (Direct) | View |
| 2023-06-07 Sale | 2023-06-09 2:32 pm | Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director | 3,300 | $51.82 | $171,006 | 34,165 (Direct) | View |
| 2022-07-13 Sale | 2022-07-15 4:30 pm | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 5,700 | $20.96 | $119,455 | 12,536 (Direct) | View |
| 2021-11-04 Sale | 2021-11-05 4:28 pm | Atara Biotherapeutics Inc. | ATRA | Fust Matthew K Director | 13,354 | $19.5 | $260,403 | 31,500 (Direct) | View |
| 2021-11-01 Sale | 2021-11-03 4:55 pm | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 8,954 | $25.5 | $228,327 | 24,628 (Direct) | View |
| 2021-09-08 Sale | 2021-09-09 5:00 pm | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 6,046 | $25.5 | $154,173 | 33,582 (Direct) | View |
| 2021-07-26 Sale | 2021-07-27 8:00 pm | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 5,000 | $19.59 | $97,950 | 39,628 (Direct) | View |
| 2021-07-19 Sale | 2021-07-20 5:00 pm | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 5,000 | $19.5 | $97,500 | 44,628 (Direct) | View |
| 2021-07-12 Sale | 2021-07-13 5:00 pm | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 5,000 | $20.71 | $103,550 | 49,628 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-09-26 Exercise | 2025-09-30 4:41 pm | N/A 2028-03-16 | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 10,000 | $0 | 24,928 (Direct) | View |
| 2025-09-26 Exercise | 2025-09-30 4:41 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 10,000 | $1.91 | 24,928 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:30 pm | N/A 2035-06-11 | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 17,250 | $0 | 39,186 (Direct) | View |
| 2025-06-10 Option Award | 2025-06-12 8:39 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Fust Matthew K Director | 7,828 | $0 | 18,188 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-30 6:30 pm | N/A 2031-04-23 | Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director | 221,959 | $0 | 221,959 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-19 6:32 pm | N/A 2035-05-15 | Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director | 16,527 | $0 | 36,732 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-18 4:30 pm | N/A 2031-04-23 | Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director | 141,959 | $0 | 141,959 (Direct) | View |
| 2024-10-17 Exercise | 2024-10-18 6:25 pm | N/A 2030-09-07 | Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director | 21,788 | $0 | 205,321 (Direct) | View |
| 2024-10-17 Exercise | 2024-10-18 6:25 pm | N/A N/A | Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director | 10,000 | $2.52 | 205,321 (Direct) | View |
| 2024-10-17 Exercise | 2024-10-18 6:25 pm | N/A N/A | Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director | 8,005 | $8.79 | 205,321 (Direct) | View |
| 2024-10-17 Exercise | 2024-10-18 6:25 pm | N/A N/A | Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director | 3,783 | $8.32 | 205,321 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 2:26 pm | N/A 2034-06-18 | Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director | 15,245 | $0 | 30,105 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 4:13 pm | N/A 2034-06-12 | Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director | 48,671 | $0 | 48,671 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-11 4:19 pm | N/A 2034-06-07 | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 15,900 | $0 | 34,436 (Direct) | View |
| 2024-03-31 Option Award | 2024-04-02 6:13 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Fust Matthew K Director | 150,000 | $0 | 259,000 (Direct) | View |
| 2024-03-20 Exercise | 2024-03-22 4:31 pm | N/A 2029-06-20 | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 60,000 | $0 | 18,536 (Direct) | View |
| 2024-03-20 Exercise | 2024-03-22 4:31 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 17,500 | $18.29 | 18,536 (Direct) | View |
| 2024-03-20 Exercise | 2024-03-22 4:31 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 17,500 | $20.23 | 18,536 (Direct) | View |
| 2024-03-20 Exercise | 2024-03-22 4:31 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 12,500 | $23.23 | 18,536 (Direct) | View |
| 2024-03-20 Exercise | 2024-03-22 4:31 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 12,500 | $23.24 | 18,536 (Direct) | View |
| 2023-09-14 Option Award | 2023-09-18 5:51 pm | N/A 2033-09-13 | Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director | 27,802 | $0 | 27,802 (Direct) | View |
Ownership | 2023-09-14 6:57 pm | N/A 2030-09-07 | Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director | 0 | $0 | 107,374 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 5:00 pm | N/A 2033-06-15 | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 23,500 | $0 | 36,036 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 2:32 pm | N/A 2033-06-07 | Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director | 10,970 | $0 | 34,165 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 7:09 pm | N/A 2033-05-30 | Atara Biotherapeutics Inc. | ATRA | Fust Matthew K Director | 136,500 | $0 | 188,500 (Direct) | View |
| 2022-07-13 Exercise | 2022-07-15 4:30 pm | N/A 2027-11-05 | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 5,700 | $0 | 12,536 (Direct) | View |
| 2022-07-13 Exercise | 2022-07-15 4:30 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 5,700 | $1.45 | 12,536 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-28 1:52 pm | N/A 2032-06-24 | Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director | 9,545 | $0 | 32,740 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 4:48 pm | N/A 2032-06-22 | Atara Biotherapeutics Inc. | ATRA | Fust Matthew K Director | 52,000 | $0 | 83,500 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-21 4:46 pm | N/A 2032-06-16 | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2022-03-04 Exercise | 2022-03-08 12:25 pm | N/A 2024-07-10 | Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director | 7,500 | $0 | 23,195 (Direct) | View |
| 2022-03-04 Exercise | 2022-03-08 12:25 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director | 7,500 | $40.37 | 23,195 (Direct) | View |
| 2021-11-01 Exercise | 2021-11-03 4:55 pm | N/A 2028-03-16 | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 8,954 | $0 | 24,628 (Direct) | View |
| 2021-11-01 Exercise | 2021-11-03 4:55 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 8,954 | $1.91 | 24,628 (Direct) | View |
| 2021-09-08 Exercise | 2021-09-09 5:00 pm | N/A 2028-03-16 | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 6,046 | $0 | 33,582 (Direct) | View |
| 2021-09-08 Exercise | 2021-09-09 5:00 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 6,046 | $1.91 | 33,582 (Direct) | View |
| 2021-07-26 Exercise | 2021-07-27 8:00 pm | N/A 2028-03-16 | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 5,000 | $0 | 39,628 (Direct) | View |
| 2021-07-26 Exercise | 2021-07-27 8:00 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 5,000 | $1.91 | 39,628 (Direct) | View |
| 2021-07-19 Exercise | 2021-07-20 5:00 pm | N/A 2028-03-16 | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 5,000 | $0 | 44,628 (Direct) | View |
| 2021-07-19 Exercise | 2021-07-20 5:00 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 5,000 | $1.91 | 44,628 (Direct) | View |
| 2021-07-12 Exercise | 2021-07-13 5:00 pm | N/A 2028-03-16 | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 5,000 | $0 | 49,628 (Direct) | View |
| 2021-07-12 Exercise | 2021-07-13 5:00 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 5,000 | $1.91 | 49,628 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 6:24 pm | N/A 2031-06-24 | Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director | 6,270 | $0 | 19,820 (Direct) | View |
| 2021-06-22 Option Award | 2021-06-23 5:00 pm | N/A 2031-06-21 | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-09 7:05 pm | N/A 2031-06-07 | Atara Biotherapeutics Inc. | ATRA | Fust Matthew K Director | 28,500 | $0 | 62,354 (Direct) | View |